argenx SE (ARGX)
387.00
-1.34
(-0.35%)
USD |
NASDAQ |
Jun 14, 16:00
386.77
-0.23
(-0.06%)
After-Hours: 20:00
argenx Cash from Operations (Quarterly)
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | -285.44M |
| June 30, 2022 | -494.51M |
| June 30, 2021 | -225.07M |
| June 30, 2019 | 259.62M |
| June 30, 2018 | -31.90M |
| June 30, 2017 | -17.53M |
| Date | Value |
|---|---|
| June 30, 2016 | 25.01M |
| June 30, 2015 | -6.108M |
| June 30, 2014 | 0.3096M |
| March 31, 2014 | -3.217M |
| June 30, 2013 | -2.029M |
| March 31, 2013 | -3.477M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-494.51M
Minimum
Jun 2022
259.62M
Maximum
Jun 2019
-186.35M
Average
-255.25M
Median
Cash from Operations (Quarterly) Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| Koninklijke Philips NV | -- |
| Qiagen NV | 133.08M |
| Trinity Biotech PLC | -2.819M |
| Mereo BioPharma Group PLC | -7.991M |
Cash from Operations (Quarterly) Related Metrics
| Free Cash Flow Yield | -4.05% |